hypertension Archives
Vanderbilt University Medical Center offers surgical option for form of pulmonary hypertension
Nov. 18, 2014—A copy repairman who couldn’t do his job anymore and was forced to take medical leave has returned to work. A woman who couldn’t walk from her car to her desk job has enough energy to redecorate her house. A 42-year-old mother who was too sick to care for her children and was discharged to...
Overactive stress response in obesity
Nov. 7, 2014—An overactive stress response contributes to the development of insulin resistance in obese individuals, and blocking it may be therapeutically beneficial.
Immune cells’ role in hypertension
Oct. 24, 2014—Vanderbilt researchers have discovered that certain immune cells contribute to the development of hypertension, suggesting novel targets for treating the disease.
Vanderbilt Hypertension Clinic receives national comprehension designation
Jan. 29, 2014—The American Society of Hypertension (ASH) has recognized the Vanderbilt Hypertension Clinic as an ASH Designated Comprehensive Hypertension Center. The designation highlights Vanderbilt’s expertise in evaluating, diagnosing and treating high blood pressure – particularly treatment-resistant forms of the condition. Hypertension is a major risk factor for heart disease, stroke, aneurysms and kidney disease. Nearly 70...
Study tracks skin salt’s role in blood pressure control
Jun. 6, 2013—Clinical pharmacologist Jens Titze, M.D., and his colleagues have identified a new cast of cells and molecules that function in the skin to control sodium balance and blood pressure.
Laffer named director of Hypertension Service
Jan. 17, 2013—Cheryl Laffer, M.D., PhD., professor of Medicine, is the new director of the Hypertension Service within the Division of Clinical Pharmacology.
Better blood pressure-reducing drugs?
Apr. 30, 2012—A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome.
Combo combats dizziness
Mar. 9, 2012—Some patients may need a combo of medications to combat a condition that causes dizziness.
Meds’ benefits differ in dialysis patients
Jan. 5, 2012—About half of kidney patients will die from heart disease within five years of starting dialysis, yet patients with kidney failure are rarely included in heart disease research. Jorge Gamboa, M.D., T. Alp Ikizler, M.D., and Nancy Brown, M.D., completed a small study that suggests a more personalized approach to selecting medication for heart disease...
